Ambri gets new business software
Wednesday, 01 May, 2002
Ambri has adopted new business software and services from Frontstep, to help it to take its new clinical diagnostic system from prototype to full-scale manufacture.
Ambri's CEO and managing director, Joe Shaw, said Frontstep's solution will provide a flexible and highly scalable platform for the company as it moves closer toward establishing commercial manufacturing operations and its North American expansion.
Frontsteps' SyteLine provides a business management platform that will allow Ambri to satisfy the US Food and Drug Administration regulations.
"We will not become a global organisation without people and suppliers who are dedicated to joining with us to achieve this objective," said Shaw.
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
Existing medicines could help treat deadly childhood dementia
Australian researchers have identified several existing TGA‑approved medicines that could help...
Statins reduce heart attack and stroke risk in older people
It has previously been unclear whether statins were effective in reducing heart attack and stroke...
